MAPT and Alzheimer disease: Therefore, the APP/PS1 mouse model has been widely used in the study of AD, which is a pathological model with Aβ aggregation and senile plaque deposition, tau hyperphosphorylation, and synaptic dysfunction, which is also consistent with our experimental results.